90/012,466Liquid Adenovirus Formulations7,888,096Closed

Status

Reexamination Certificate Issued

Filed

Sep 6, 2012

Last Updated

Dec 27, 2013

Art Unit

3991

Requester Law Firm

Unknown

Requested By

Third Party

Patent OwnerInferred

Crucell Holland B.V.

Sector (CPC)

CChemistry & Materials
C12Biotechnology
C12NMicroorganisms & Enzymes

USPC

435Chemistry: Molecular Biology And Microbiology

Reexam History (33 events)

Dec 27, 2013REEXInput Issue Number and Issue Date for Reexamination
Dec 11, 2013RXPUBSReexam Forwarded to Office of Publications
Dec 3, 2013MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Nov 21, 2013RXLITSRReexam Litigation Search Conducted
Nov 11, 2013RXSA..Supplemental Response after Non-Final Rejection
Nov 11, 2013RXC/SRCertificate of Service
May 13, 2013RXSA..Supplemental Response after Non-Final Rejection
May 13, 2013RXC/SRCertificate of Service
May 13, 2013RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Apr 22, 2013RXC/SRCertificate of Service
Apr 22, 2013RXIDS.Information Disclosure Statement Filed
Apr 22, 2013IDSCInformation Disclosure Statement considered
Apr 22, 2013WIDSInformation Disclosure Statement (IDS) Filed
Apr 19, 2013RXAIRX - Informal / NonResponsive Amendment after Examiner Action
Apr 19, 2013RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Apr 19, 2013RXC/SRCertificate of Service
Feb 22, 2013MR.NFRX - Mail Reexam Non-Final Action
Jan 29, 2013RXFWDXDate Forwarded to Examiner
Dec 21, 2012RXC/SRCertificate of Service
Dec 21, 2012RXIDS.Information Disclosure Statement Filed
Dec 21, 2012RCCPRX - Concurrent Proceedings Notice
Oct 29, 2012MREXORX - Mail Ex Parte Request for Reexamination Granted
Oct 24, 2012MREXNRX - Mail Examiner Interview Summary Record
Oct 23, 2012NRX.Notice of Reexam Published in Official Gazette
Sep 18, 2012DOCKCase Docketed to Examiner in GAU
Sep 14, 2012MRXNReexamination Formalities Notice Mailed
Sep 14, 2012MRXNReexamination Formalities Notice Mailed
Sep 13, 2012RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Sep 11, 2012RXTTLRPTTitle Report
Sep 10, 2012RXLITSRReexam Litigation Search Conducted
Sep 6, 2012RXOSUB.RReexamination requested by third party requester
Sep 6, 2012RXIDS.Information Disclosure Statement Filed
Sep 6, 2012RXOSUBReceipt of Original Ex Parte Reexam Request

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedJan 29, 2010

Prosecution History

DateCodeDescription
Mar 22, 2010P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Jan 29, 2010DISTTerminal Disclaimer Filed
Jan 29, 2010DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Feb 15, 2011
3.5-yr
Aug 15, 2014
7.5-yr
Aug 15, 2018
Paid Aug 2, 2018
11.5-yr
Aug 15, 2022
Expiry
Aug 13, 2028

Entity Status

Large Entity

Expires

Aug 13, 2028 (2.4 yr remaining)

Term Adjustment

+414 days (~1.1 yr)

Other

USPTO Event: Expire PatentUSPTO Event: Maintenance Fee Reminder Mailed

Assignments

Jul 2007Aug 2007Sep 2007Oct 2007Nov 2007Dec 2007Jan 2008Feb 2008Mar 2008Apr 2008May 2008Jun 2008Jul 2008Aug 2008Sep 2008Oct 2008Nov 2008Dec 2008Jan 2009Feb 2009Mar 2009Apr 2009May 2009FiledINTROGEN THERAPEUTICS, INC.CRUCELL HOLLAND B.V.
AssignmentReel/Frame: 023279/0858Recorded: Sep 24, 2009

From

INTROGEN THERAPEUTICS, INC.
May 15, 2009

To

CRUCELL HOLLAND B.V.